Expanding zip codes: A novel approach to reaching and engaging clinical trial participants across the United States

The webinar presenters define the need for expanding participants across clinical trials and explore a novel method for engagement and retention. 

We are faced with the reality that a drug may not work in certain individuals because it does not mirror a real-world population. There are many hurdles in reaching a broader population of clinical trial participants, which can lead to insufficient data on a drug’s efficacy and safety.

​Of interest to:

  • Clinical trial operations

  • Community leaders

  • Medical device/biotech

  • Pharmacists

  • Pharmacy executives​​​​​​

​​​​​​​

​​What you will learn

  • The existing hurdles in expanding clinical trial participation, including social factors such as mistrust of the medical system.

  • Real-world initiatives within the pharmaceutical industry to expand reach across rural communities in the United States.

  • A novel approach to engaging and maintaining clinical trial participants in rural as well as urban regions within the United States.

Speakers

Carissa Jones

Founder, Ventus, LLC

Carissa has supported the pharmaceutical research and in-vitro diagnostics sectors in the field of cardiometabolism. She built the US operations for a Swedish immunoassay company, Mercodia, and helped them expand their business through the addition of a bioanalytical laboratory service in the US. Today she is the founder of a consulting firm built upon her experience in the field of immunoassay and laboratory science with a focus on those entertaining entrance into the US market.

William (Bill) Annes

Founder, Ventus, LLCSenior Director, Clinical Laboratory Sciences, Eli Lilly

William (Bill) Annes leads global strategies for biomarker integration, lab operations, and clinical diagnostics across diverse therapeutic programs. With a career spanning translational science and patient-centered research, Bill has played a pivotal role in advancing laboratory capabilities in China and other emerging markets, ensuring scientific rigor and operational excellence in complex clinical environments. His recent work includes navigating regulatory and logistical challenges for investigational products and diagnostics, and supporting biomarker-driven studies that bridge global standards with local feasibility. Bill is passionate about aligning scientific innovation with practical patient care, and fostering collaboration across clinical, regulatory, and operational teams.

Gerald E Finken

CEO, RxE2

Gerald is a licensed pharmacist with over 40 years of experience in the biotechnology and pharmaceutical industries. In 1997, he founded CSM, a clinical supplies packaging and labeling company, where he invented On-Demand packaging and labeling, Clinical Trial Research Pharmacist (CTRP®) services, and pioneered Direct-to-Patient services. In 2013, he founded Center Point Clinical Services and subsequently created the innovative Siteless CRO model. In 2020, Gerald launched RxE2 where he now serves as CEO and is bringing the practice of pharmacy to clinical trials.

Neil Spooner

Director Spooner Bioanalytical Solutions & Chair Patient Centric Sampling Interest Group

Neil is the Founder of Spooner Bioanalytical Solutions, helping companies to integrate biological fluid microsampling, and patient centric sampling and analysis into workflows. He also works with organizations to develop technologies and introduce them to the market. Neil also assists organizations with their understanding of emerging trends in the pharmaceutical industry and bioanalysis. Neil is a Senior Visiting Research Fellow at the University of Hertfordshire, Editor in Chief of the journal, Bioanalysis, Founder of the Patient Centric Sampling Interest Group and Co-Chair of the Reid Bioanalytical Forum. He has published over 70 peer reviewed manuscripts and delivered over 50 podium presentations.​​​​​​​

In association with